Whittier Trust’s Exelixis EXEL Stock Holding History

Whittier Trust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,500	Closed	-$252K	–	1522
2023 Q4	$252K	Buy	10,500 +10,492	+131,150%	+$228K	﹤0.01%	599
2023 Q3	$174	Buy	+8	New	+$167	﹤0.01%	1639

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Whittier Trust's EXEL Position: Q1 2024 in Review

Whittier Trust sold out of Exelixis (EXEL) in Q1 2024, closing a stake of 10,500 shares — an estimated $252K sold.

Whittier Trust first reported a position in EXEL in Q3 2023 and held it in 2 quarters. The position peaked at $252K in Q4 2023. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

Whittier Trust reported no remaining Exelixis position as of Q1 2024 after selling out during the quarter.
Whittier Trust sold 10,500 Exelixis shares in Q1 2024, an estimated $252K.
Whittier Trust first reported a position in Exelixis in Q3 2023 and held it in 2 quarters.
Whittier Trust's Exelixis position peaked at $252K in Q4 2023.
422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Whittier Trust's 13F filing for Q1 2024, filed 2 May 2024.